SASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation.
Animals
B-Lymphocytes
/ immunology
CD4-Positive T-Lymphocytes
/ immunology
Child, Preschool
Chromosomes, Human, X
/ genetics
Genetic Loci
Humans
Jurkat Cells
Killer Cells, Natural
/ immunology
Lymphopenia
/ genetics
Male
Mice
Mice, Knockout
Mutation
Receptors, Antigen, T-Cell, alpha-beta
/ genetics
X-Linked Combined Immunodeficiency Diseases
/ genetics
Journal
Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509
Informations de publication
Date de publication:
23 09 2021
23 09 2021
Historique:
pubmed:
21
4
2021
medline:
15
12
2021
entrez:
20
4
2021
Statut:
ppublish
Résumé
Sterile alpha motif (SAM) and Src homology-3 (SH3) domain-containing 3 (SASH3), also called SH3-containing lymphocyte protein (SLY1), is a putative adaptor protein that is postulated to play an important role in the organization of signaling complexes and propagation of signal transduction cascades in lymphocytes. The SASH3 gene is located on the X-chromosome. Here, we identified 3 novel SASH3 deleterious variants in 4 unrelated male patients with a history of combined immunodeficiency and immune dysregulation that manifested as recurrent sinopulmonary, cutaneous, and mucosal infections and refractory autoimmune cytopenias. Patients exhibited CD4+ T-cell lymphopenia, decreased T-cell proliferation, cell cycle progression, and increased T-cell apoptosis in response to mitogens. In vitro T-cell differentiation of CD34+ cells and molecular signatures of rearrangements at the T-cell receptor α (TRA) locus were indicative of impaired thymocyte survival. These patients also manifested neutropenia and B-cell and natural killer (NK)-cell lymphopenia. Lentivirus-mediated transfer of the SASH3 complementary DNA-corrected protein expression, in vitro proliferation, and signaling in SASH3-deficient Jurkat and patient-derived T cells. These findings define a new type of X-linked combined immunodeficiency in humans that recapitulates many of the abnormalities reported in mice with Sly1-/- and Sly1Δ/Δ mutations, highlighting an important role of SASH3 in human lymphocyte function and survival.
Identifiants
pubmed: 33876203
pii: S0006-4971(21)00893-4
doi: 10.1182/blood.2020008629
pmc: PMC8462359
doi:
Substances chimiques
Receptors, Antigen, T-Cell, alpha-beta
0
Types de publication
Clinical Trial
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1019-1033Subventions
Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA AI001222
Pays : United States
Informations de copyright
© 2021 by The American Society of Hematology.
Références
Blood Adv. 2020 Jun 23;4(12):2611-2616
pubmed: 32556283
Sci Signal. 2013 Oct 15;6(297):ra92
pubmed: 24129702
J Clin Immunol. 2020 Jan;40(1):24-64
pubmed: 31953710
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W382-8
pubmed: 15980494
Nat Immunol. 2002 May;3(5):469-76
pubmed: 11967541
Mol Cell Biol. 2005 Nov;25(21):9646-60
pubmed: 16227612
Nat Metab. 2019 Jul;1(7):717-730
pubmed: 32373781
Nat Med. 2000 May;6(5):543-8
pubmed: 10802710
J Biol Chem. 2003 Mar 14;278(11):9267-75
pubmed: 12515807
Biochim Biophys Acta. 2001 Jul 30;1520(1):89-93
pubmed: 11470164
J Allergy Clin Immunol. 2019 Jun;143(6):2317-2321.e12
pubmed: 30822429
J Allergy Clin Immunol. 2015 Jun;135(6):1578-88.e5
pubmed: 25842288
Nat Immunol. 2016 Aug;17(8):946-55
pubmed: 27348411
Nucleic Acids Res. 2018 Jan 4;46(D1):D428-D434
pubmed: 29136216
BMC Immunol. 2009 Jul 15;10:38
pubmed: 19604361
Eur J Immunol. 2015 Nov;45(11):3087-97
pubmed: 26306874
Oncoimmunology. 2016 Sep 27;5(12):e1238543
pubmed: 28123874
Nucleic Acids Res. 2015 Jan;43(Database issue):D512-20
pubmed: 25514926
Nat Methods. 2016 Feb;13(2):109-10
pubmed: 26820543
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Sci Rep. 2019 Jan 10;9(1):54
pubmed: 30631134
Mol Immunol. 2009 Feb;46(5):969-77
pubmed: 18950867
Int J Mol Sci. 2018 Dec 20;20(1):
pubmed: 30577453
J Allergy Clin Immunol. 2019 Jan;143(1):325-334.e2
pubmed: 29906526
J Allergy Clin Immunol. 2019 Jul;144(1):333-336
pubmed: 31053347
N Engl J Med. 2008 May 8;358(19):2030-8
pubmed: 18463379
J Allergy Clin Immunol. 2017 Apr;139(4):1302-1310.e4
pubmed: 27658761
Front Immunol. 2017 Jul 17;8:798
pubmed: 28769923
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1412-1420
pubmed: 30869812
Sci Immunol. 2020 Jul 24;5(49):
pubmed: 32709702
Science. 2015 Aug 7;349(6248):606-613
pubmed: 26160376
J Allergy Clin Immunol. 2015 Oct;136(4):993-1006.e1
pubmed: 26162572
Nat Immunol. 2014 Sep;15(9):798-807
pubmed: 25137454
Bioinformatics. 2017 May 1;33(9):1402-1404
pubmed: 28453683
Nat Immunol. 2010 Feb;11(2):162-70
pubmed: 20010845
Blood. 2018 May 24;131(21):2335-2344
pubmed: 29653965
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W597-600
pubmed: 23671338
Nat Protoc. 2012 Jul 19;7(8):1511-22
pubmed: 22814390